Cross-talk between angiogenic growth factors.
- Beverly L. Falcon (628324)
- Michelle Swearingen (628325)
- Wendy H. Gough (628326)
- Linda Lee (163668)
- Robert Foreman (628327)
- Mark Uhlik (628328)
- Jeff C. Hanson (628329)
- Jonathan A. Lee (628330)
- Don B. McClure (628331)
- Sudhakar Chintharlapalli (628332)
Publication date
September 2014
DOIAbstract
<p>Basal, VEGF-, bFGF-, or EGF-driven cords were treated with a VEGFR-2 antibody (IMC-1121B; Ramucirumab; Ram), a bFGF antibody (anti-bFGF), or an EGFR inhibitor (Gefitinib) and the percent inhibition of total tube area from the ArrayScan was graphed. n = 3 per group.</p
Add to ORKG